Rare Disease Genetic Testing Market

Rare Disease Genetic Testing Market contains market size and forecasts of Rare Disease Genetic Testing in Global, including the following market information:
Global Rare Disease Genetic Testing Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Rare Disease Genetic Testing market was valued at 846.8 million in 2021 and is projected to reach US$ 1859.8 million by 2028, at a CAGR of 11.9% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Next-Generation Sequencing (NGS) Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Rare Disease Genetic Testing include Quest Diagnostics, Centogene, Invitae Corporation, 3billion, Arup Laboratories, Eurofins Scientific, Strand Life Sciences, Ambry Genetics and Perkin Elmer, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Rare Disease Genetic Testing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Rare Disease Genetic Testing Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Rare Disease Genetic Testing Market Segment Percentages, by Type, 2021 (%)
Next-Generation Sequencing (NGS)
Array Technology
PCR-based Testing
Fluorescence in Situ Hybridization (FISH)
Sanger Sequencing
Karyotyping
Others
Global Rare Disease Genetic Testing Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Rare Disease Genetic Testing Market Segment Percentages, by Application, 2021 (%)
Research Laboratories and CROs
Diagnostic Laboratories
Hospitals and Clinics
Others
Global Rare Disease Genetic Testing Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Rare Disease Genetic Testing Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Rare Disease Genetic Testing revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Rare Disease Genetic Testing revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Quest Diagnostics
Centogene
Invitae Corporation
3billion
Arup Laboratories
Eurofins Scientific
Strand Life Sciences
Ambry Genetics
Perkin Elmer
Macrogen
Baylor Genetics
Color Genomics
Preventiongenetics
Progenity
Coopersurgical
Fulgent Genetics
Myriad Genetics
LabCorp
Opko Health